Medicare Enrolled
Dr. Debra Bakal, M.D.
Dermatopathology Physician · Hoffman Estates, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bakal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bakal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bakal
Dr. Debra Bakal is a dermatopathology physician in Hoffman Estates, IL, with 21 years of NPI registration. Based on federal Medicare data, Dr. Bakal performed 1,963 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bakal received a total of $9,637 from 46 pharmaceutical and/or device companies across 452 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bakal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ 1,963 Medicare services
$9,637 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,963
Medicare services
Bottom 27% in IL for dermatopathology physician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
666 | $67 | $110 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
344 | $5 | $8 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
249 | $72 | $125 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
229 | $41 | $82 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
114 | $43 | $62 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
77 | $75 | $144 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
74 | $101 | $157 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $43 | $69 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
46 | $83 | $140 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
22 | $77 | $150 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
17 | $88 | $155 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
16 | $34 | $70 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
16 | $1 | $1 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
13 | $50 | $88 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $134 | $217 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,637
Total received (2018-2024)
Avg $1,377/year across 7 years
Top 28% in IL for dermatopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
452
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,892
2023
$2,295
2022
$1,592
2021
$697
2020
$387
2019
$1,237
2018
$1,537
Payments by company (2024)
Lilly USA, LLC
$442
UCB, Inc.
$411
Regeneron Healthcare Solutions, Inc.
$227
ABBVIE INC.
$154
Incyte Corporation
$146
LEO Pharma Inc.
$88
Almirall LLC
$80
Novartis Pharmaceuticals Corporation
$69
E.R. Squibb & Sons, L.L.C.
$58
Amgen Inc.
$54
GENZYME CORPORATION
$36
Verrica Pharmaceuticals Inc.
$34
Biofrontera Inc.
$34
MAYNE PHARMA COMMERCIAL LLC
$30
PFIZER INC.
$17
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Top 3 companies account for 57.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,295
Regeneron Healthcare Solutions, Inc.
$665
Sun Pharmaceutical Industries Inc.
$651
Janssen Biotech, Inc.
$632
ABBVIE INC.
$602
UCB, Inc.
$602
Incyte Corporation
$556
AbbVie Inc.
$527
Amgen Inc.
$496
PFIZER INC.
$364
GENZYME CORPORATION
$338
Ortho Dermatologics, a division of Bausch Health US, LLC
$311
AbbVie, Inc.
$281
Galderma Laboratories, L.P.
$264
Novartis Pharmaceuticals Corporation
$239
Mayne Pharma Inc.
$185
LEO Pharma Inc.
$134
Almirall LLC
$131
E.R. Squibb & Sons, L.L.C.
$128
Celgene Corporation
$114
Merz North America, Inc.
$103
Dermavant Sciences, Inc.
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$82
Smith+Nephew, Inc.
$78
Biofrontera Inc.
$73
SANOFI-AVENTIS U.S. LLC
$70
DERMIRA, INC.
$69
Promius Pharma LLC
$63
EPI Health, LLC
$54
DUSA Pharmaceuticals, Inc.
$50
Allergan Inc.
$49
Encore Dermatology Inc.
$43
Verrica Pharmaceuticals Inc.
$34
MAYNE PHARMA COMMERCIAL LLC
$30
Janssen Scientific Affairs, LLC
$29
Krystal Biotech Inc
$26
VYNE Pharmaceuticals Inc.
$24
Nabriva Therapeutics, plc
$20
Kyowa Kirin, Inc.
$19
Genentech USA, Inc.
$19
Allergan, Inc.
$18
MAYNE PHARMA INC.
$17
Aclaris Therapeutics, Inc.
$16
Merck Sharp & Dohme Corporation
$14
Mission Pharmacal Company
$12
Melinta Therapeutics, Inc.
$11
Top 3 companies account for 27.1% of all-time payments
Associated products mentioned in payments ›
ABSORICA (isotretinoin) · ADBRY · AKLIEF · ALTRENO · AMELUZ · ARAZLO · Ameluz · Avar · BLU-U · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · BOTOX · BOTOX COSMETIC · BRYHALI · Baxdela · Bensal HP · Bimzelx · CIBINQO · COSENTYX · Cimzia · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · GRAFIX PL · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · LEVULAN KERASTICK · LIBTAYO · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · POTELIGEO · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · Sernivo Spray · Seysara · Sitavig · Sivextro · Sotyktu · TALTZ · TREMFYA · Tremfya · Trianex · VTAMA · VYJUVEK · Winlevi · YCANTH · ZILXI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatopathology physicians in nearby ZIP areas
7
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
ST ALEXIUS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bakal is a clinical cardiology specialist, with moderate Medicare volume, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bakal experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Bakal performed 666 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bakal receive payments from pharmaceutical companies?
Yes. Dr. Bakal received a total of $9,637 from 46 companies across 452 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bakal's costs compare to other dermatopathology physicians in Hoffman Estates?
Dr. Bakal's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bakal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in Hoffman Estates
Browse dermatopathology physicians in Hoffman Estates ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in IL
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in IL
Which IL dermatopathology physicians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Sun Pharmaceutical Industries Inc. Payments to Doctors
See all physicians who received payments from Sun Pharmaceutical Industries Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology